This can help anticipate symptoms and prevent the progression of the disease. Self-monitoring with biosensors has the potential to impact the care of virtually any chronic disease, by shifting from a monthly appointment at the hospital to daily monitoring at home. Medtech companies are working to develop smaller, cheaper, and easier to use biosensor devices that anyone could use at home. However, the fastest-growing segment of the biosensor market is home monitoring kits, such as glucose monitors used by diabetics. In this area we see companies such as Luciole Medical in Switzerland, which is developing a minimally invasive probe to measure blood oxygen levels in the brain for intensive care. Home monitoringĬurrently, point-of-care applications constitute the main use of biosensors.
It is predicted to reach a massive €27B by 2020, pushed by a wave of new technologies that are making them more accessible both for patients and consumers. The market for biosensors is growing rapidly. These devices are able to detect a specific molecule that is linked to a health condition, offering an actionable insight into what’s happening in our bodies. Traditionally used in medical practice to monitor patient status, biosensors have recently started to be broadly marketed for wellness and fitness applications. As technology advances, we may soon be able to monitor many aspects of our health at home, in real time, and without needles. Biosensors are rapidly becoming part of our everyday life.
0 kommentar(er)
